Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials
Hebert, A. A., Flohr, C., Hong, H. C. H., Irvine, A. D., Pierce, E., Elmaraghy, H., Pillai, S., Dawson, Z., Chen, S., Armengol, C., Siegfried, E. & Weidinger, S., 12 May 2024, In: JOURNAL OF DERMATOLOGICAL TREATMENT. 35, 1, 2324833.
Research output: Contribution to journal › Article › peer-review